- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1942
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Signaling COVID-19 Vaccine Adverse Events ; volume:45 ; number:7 ; day:23 ; month:6 ; year:2022 ; pages:765-780 ; date:7.2022
Drug safety ; 45, Heft 7 (23.6.2022), 765-780, 7.2022
- Creator
-
Harpaz, Rave
DuMouchel, William
Manen, Robbert Van
Nip, Alexander
Bright, Steve
Szarfman, Ana
Tonning, Joseph
Lerch, Magnus
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40264-022-01186-z
- URN
-
urn:nbn:de:101:1-2022100122373472939955
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Harpaz, Rave
- DuMouchel, William
- Manen, Robbert Van
- Nip, Alexander
- Bright, Steve
- Szarfman, Ana
- Tonning, Joseph
- Lerch, Magnus
- SpringerLink (Online service)
Other Objects (12)
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Correction: Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
A statistical analysis of vaccine-adverse event data
COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Vaccination status, incidence of adverse events, and awareness of COVID-19 vaccine among outpatients undergoing chemotherapy
Assessment of adverse events among healthcare workers following the Janssen COVID-19 vaccine in Tigray, Ethiopia
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Correction: Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
A statistical analysis of vaccine-adverse event data
COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Vaccination status, incidence of adverse events, and awareness of COVID-19 vaccine among outpatients undergoing chemotherapy
Assessment of adverse events among healthcare workers following the Janssen COVID-19 vaccine in Tigray, Ethiopia
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine
Correction to: Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
Correction: Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
A statistical analysis of vaccine-adverse event data
COVID-19 vaccine and menstrual conditions in female: data analysis of the Vaccine Adverse Event Reporting System (VAERS)
Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran
Vaccination status, incidence of adverse events, and awareness of COVID-19 vaccine among outpatients undergoing chemotherapy
Assessment of adverse events among healthcare workers following the Janssen COVID-19 vaccine in Tigray, Ethiopia
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine